Dysfunctional Telomeres, Checkpoints and Aging

功能失调的端粒、检查点和衰老

基本信息

  • 批准号:
    7484951
  • 负责人:
  • 金额:
    $ 27.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-09-30 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Telomeres are specialized capping structures on chromosomes that play important roles in aging, cancer and genome stability. With each cell division, telomeres progressively shorten such that upon reaching a critical stage, they signal cells to stop dividing. This process likely prevents cells from acquiring mutations that may result in cancer or aging. When mutations occur in crucial genes that regulate telomere maintenance or checkpoint responses (such as p53 and ATM), telomeres become critically shortened and dysfunctional. Our recent findings linking telomere dysfunction to precursor/stem cell depletion and accelerated aging in the combined telomerase Atm mutant mouse model provide a unique opportunity and genetic platform to explore the molecular mechanisms by which telomere dysfunction contributes to aging, organ homeostasis and tumorigenesis. We hypothesize that mice engineered to have critically short telomeres and defective checkpoint responses due to mTerc and Atm deficiency will be predisposed to either accelerated aging or tumorigenesis depending on p53 status. We also believe that reconstitution of telomerase activity in different organ compartments of these mice will, depending on the state of the genome at the time of the reconstitution, either strongly promote organ specific tumor progression or rescue the organ stem/progenitor cell depletion phenotype as well as suppressing tumorigenesis. Lastly, detailed molecular characterization of pathways leading to activation of p53 function in primary cells and tissues from these compound mutant mice with accelerated aging and precursor/stem cell depletion will dissect the molecular pathways that are involved in the process of aging and organ homeostasis.
描述(由申请人提供):端粒是染色体上的专门的加帽结构,在衰老、癌症和基因组稳定性中起重要作用。随着每次细胞分裂,端粒逐渐缩短,当达到关键阶段时,它们会发出信号让细胞停止分裂。这个过程可能会阻止细胞获得可能导致癌症或衰老的突变。当调节端粒维持或检查点反应的关键基因(如p53和ATM)发生突变时,端粒会严重缩短并功能失调。我们最近的研究结果将端粒功能障碍与前体/干细胞耗竭和联合端粒酶Atm突变小鼠模型中的加速衰老联系起来,这为探索端粒功能障碍导致衰老、器官稳态和肿瘤发生的分子机制提供了独特的机会和遗传平台。我们假设,由于mTerc和Atm缺陷而被设计为具有严重短端粒和缺陷检查点反应的小鼠将倾向于加速衰老或肿瘤发生,这取决于p53状态。我们还相信,根据重建时基因组的状态,这些小鼠不同器官区室中端粒酶活性的重建将强烈促进器官特异性肿瘤进展或拯救器官干/祖细胞耗竭表型以及抑制肿瘤发生。最后,详细的分子表征的途径,导致激活p53功能的原代细胞和组织从这些化合物突变小鼠加速老化和前体/干细胞耗竭将解剖的分子途径,参与衰老和器官稳态的过程。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kwok Kin Wong其他文献

Kwok Kin Wong的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kwok Kin Wong', 18)}}的其他基金

Therapeutic strategies for specific subsets of KRAS mutant lung cancers
KRAS 突变肺癌特定亚型的治疗策略
  • 批准号:
    9451116
  • 财政年份:
    2017
  • 资助金额:
    $ 27.08万
  • 项目类别:
Animal Models/Experimental Therapeutics Core
动物模型/实验治疗核心
  • 批准号:
    8237138
  • 财政年份:
    2012
  • 资助金额:
    $ 27.08万
  • 项目类别:
Core C: Animal Modeling and Preclinical Therapeutics
核心 C:动物建模和临床前治疗
  • 批准号:
    10231104
  • 财政年份:
    2012
  • 资助金额:
    $ 27.08万
  • 项目类别:
Dysfunctional Telomeres, Checkpoints and Aging
功能失调的端粒、检查点和衰老
  • 批准号:
    7653672
  • 财政年份:
    2006
  • 资助金额:
    $ 27.08万
  • 项目类别:
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
EGFR 突变驱动的肺癌对放射治疗反应的体内分析
  • 批准号:
    8450878
  • 财政年份:
    2006
  • 资助金额:
    $ 27.08万
  • 项目类别:
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
EGFR 突变驱动的肺癌对放射治疗反应的体内分析
  • 批准号:
    8826566
  • 财政年份:
    2006
  • 资助金额:
    $ 27.08万
  • 项目类别:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
肿瘤发生中的 EGFRvIII 突变和对酪氨酸激酶抑制剂的敏感性
  • 批准号:
    7428779
  • 财政年份:
    2006
  • 资助金额:
    $ 27.08万
  • 项目类别:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
肿瘤发生中的 EGFRvIII 突变和对酪氨酸激酶抑制剂的敏感性
  • 批准号:
    7269241
  • 财政年份:
    2006
  • 资助金额:
    $ 27.08万
  • 项目类别:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
肿瘤发生中的 EGFRvIII 突变和对酪氨酸激酶抑制剂的敏感性
  • 批准号:
    7130431
  • 财政年份:
    2006
  • 资助金额:
    $ 27.08万
  • 项目类别:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
肿瘤发生中的 EGFRvIII 突变和对酪氨酸激酶抑制剂的敏感性
  • 批准号:
    7837568
  • 财政年份:
    2006
  • 资助金额:
    $ 27.08万
  • 项目类别:

相似海外基金

Epigenetic Age Acceleration Impacts Racial and Neighborhood Disparities in Chronic Low Back Pain
表观遗传年龄加速影响慢性腰痛的种族和社区差异
  • 批准号:
    10431156
  • 财政年份:
    2022
  • 资助金额:
    $ 27.08万
  • 项目类别:
Epigenetic Age Acceleration and Psychoneurological Symptoms in Sickle Cell Disease
镰状细胞病的表观遗传年龄加速和精神神经症状
  • 批准号:
    10594523
  • 财政年份:
    2022
  • 资助金额:
    $ 27.08万
  • 项目类别:
Early Life Cardiovascular Disease Risk Factors, Epigenetic Age Acceleration, and Alzheimer's Disease Related Brain Health
生命早期心血管疾病危险因素、表观遗传年龄加速和阿尔茨海默病相关的大脑健康
  • 批准号:
    10706044
  • 财政年份:
    2022
  • 资助金额:
    $ 27.08万
  • 项目类别:
The pathway from prenatal pregnancy-specific anxiety to offspring ADHD through epigenetic age acceleration DNA methylation and moderators to target intervention: Partner social support
通过表观遗传年龄加速 DNA 甲基化和调节因子从产前妊娠特异性焦虑到后代 ADHD 的途径:伴侣社会支持
  • 批准号:
    475968
  • 财政年份:
    2022
  • 资助金额:
    $ 27.08万
  • 项目类别:
    Studentship Programs
Epigenetic Age Acceleration and Psychoneurological Symptoms in Sickle Cell Disease
镰状细胞病的表观遗传年龄加速和精神神经症状
  • 批准号:
    10449461
  • 财政年份:
    2022
  • 资助金额:
    $ 27.08万
  • 项目类别:
Functional genetic analysis of epigenetic age acceleration and the regulatory landscape of the methylome
表观遗传年龄加速的功能遗传分析和甲基化组的调控景观
  • 批准号:
    10674263
  • 财政年份:
    2022
  • 资助金额:
    $ 27.08万
  • 项目类别:
Perinatal Maternal Anxiety and Offspring ADHD Symptoms: Mediation Through Epigenetic Age Acceleration DNA Methylation
围产期母亲焦虑和后代 ADHD 症状:通过表观遗传年龄加速 DNA 甲基化进行调节
  • 批准号:
    467256
  • 财政年份:
    2021
  • 资助金额:
    $ 27.08万
  • 项目类别:
    Studentship Programs
CAREER: Understanding the Role of Cu-Containing Secondary Phase Particles in Enhancing the Resistance to the Environmental Acceleration to Fatigue in Age-Hardenable Al Alloys
事业:了解含铜第二相颗粒在增强时效硬化铝合金的环境加速疲劳抵抗力方面的作用
  • 批准号:
    1943870
  • 财政年份:
    2020
  • 资助金额:
    $ 27.08万
  • 项目类别:
    Continuing Grant
Breast Cancer Risk Factors and Epigenetic Age Acceleration
乳腺癌危险因素和表观遗传年龄加速
  • 批准号:
    10614228
  • 财政年份:
    2020
  • 资助金额:
    $ 27.08万
  • 项目类别:
The Clock is Ticking: Epigenetic Age Acceleration as a Biomarker of Uterine Function in Pregnancy
时钟在滴答作响:表观遗传年龄加速作为妊娠期子宫功能的生物标志物
  • 批准号:
    10630244
  • 财政年份:
    2020
  • 资助金额:
    $ 27.08万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了